Startseite/Aktien/KMDA

KMDA

USD

Kamada Ltd. Ordinary Shares

$6.950+0.000 (0.000%)

Echtzeitkurs

Healthcare

Drug Manufacturers - Specialty & Generic

Israel

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$6.950

Hoch

$7.090

Tief

$6.930

Volumen

0.06M

Unternehmensfundamentaldaten

Marktkapitalisierung

403.0M

Branche

Drug Manufacturers - Specialty & Generic

Land

Israel

Handelsstatistiken

Durchschnittliches Volumen

0.09M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $4.74Aktuell $6.950Hoch $9.15

Ähnliche Nachrichten

15. Mai 2025 · 14:39

Analyst Upgrades

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

Benchmark analyst Robert Wasserman reiterates Kamada with a Buy and maintains $15 price target.

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

7. Mai 2025 · 11:00

GlobeNewswire

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

5. Mai 2025 · 11:00

GlobeNewswire

Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ TransplantationA Total of 10 Studies will be Conducted in Collaboration with